BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20534573)

  • 21. A model of a MAPK•substrate complex in an active conformation: a computational and experimental approach.
    Lee S; Warthaka M; Yan C; Kaoud TS; Piserchio A; Ghose R; Ren P; Dalby KN
    PLoS One; 2011 Apr; 6(4):e18594. PubMed ID: 21494553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression.
    Song KS; Lee TJ; Kim K; Chung KC; Yoon JH
    J Biol Chem; 2008 Oct; 283(40):26869-78. PubMed ID: 18676374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains.
    Duval DL; Jean A; Gutierrez-Hartmann A
    J Biol Chem; 2003 Oct; 278(41):39684-96. PubMed ID: 12902343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the transcription factor Ets1 in carcinoma.
    Dittmer J
    Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1.
    Samorodnitsky D; Szyjka C; Koudelka GB
    J Biol Chem; 2015 Sep; 290(36):22101-10. PubMed ID: 26195629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer.
    Kasahara K; Shiina M; Fukuda I; Ogata K; Nakamura H
    PLoS One; 2017; 12(2):e0172654. PubMed ID: 28231333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
    Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence.
    Macauley MS; Errington WJ; Schärpf M; Mackereth CD; Blaszczak AG; Graves BJ; McIntosh LP
    J Biol Chem; 2006 Feb; 281(7):4164-72. PubMed ID: 16319071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors.
    Seidel JJ; Graves BJ
    Genes Dev; 2002 Jan; 16(1):127-37. PubMed ID: 11782450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis.
    Rabault B; Roussel MF; Quang CT; Ghysdael J
    Oncogene; 1996 Aug; 13(4):877-81. PubMed ID: 8761310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions.
    Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Uchiyama A; Baba S; Sato K; Yamamoto M; Ogata K
    J Mol Biol; 2015 Apr; 427(8):1655-69. PubMed ID: 25083921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
    Tsai CL; Jung SM; Chi LM; Tsai CN; Lin CY; Chao A; Lee YS
    Aging (Albany NY); 2021 May; 13(10):13739-13763. PubMed ID: 34023818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties and regulation of a transiently assembled ERK2.Ets-1 signaling complex.
    Callaway KA; Rainey MA; Riggs AF; Abramczyk O; Dalby KN
    Biochemistry; 2006 Nov; 45(46):13719-33. PubMed ID: 17105191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of Ets1 cooperative binding to widely separated sites on promoter DNA.
    Babayeva ND; Baranovskaya OI; Tahirov TH
    PLoS One; 2012; 7(3):e33698. PubMed ID: 22432043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical characterization of the ETV6 PNT domain polymerization interfaces.
    Gerak CAN; Cho SY; Kolesnikov M; Okon M; Murphy MEP; Sessions RB; Roberge M; McIntosh LP
    J Biol Chem; 2021; 296():100284. PubMed ID: 33450226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.
    John S; Russell L; Chin SS; Luo W; Oshima R; Garrett-Sinha LA
    Mol Cell Biol; 2014 Feb; 34(3):522-32. PubMed ID: 24277931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of an intrinsically disordered region of Ets1 shifts a multi-modal interaction ensemble to an auto-inhibitory state.
    Kasahara K; Shiina M; Higo J; Ogata K; Nakamura H
    Nucleic Acids Res; 2018 Mar; 46(5):2243-2251. PubMed ID: 29309620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity in structure and function of the Ets family PNT domains.
    Mackereth CD; Schärpf M; Gentile LN; MacIntosh SE; Slupsky CM; McIntosh LP
    J Mol Biol; 2004 Sep; 342(4):1249-64. PubMed ID: 15351649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA.
    Babayeva ND; Wilder PJ; Shiina M; Mino K; Desler M; Ogata K; Rizzino A; Tahirov TH
    Cell Cycle; 2010 Aug; 9(15):3054-62. PubMed ID: 20686355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.